Allay Therapeutics, Inc.

This study tested a new drug called ATX101 in 226 adults having knee replacement surgery. The goal was to see if it reduces pain and the need for opioid painkillers compared to a placebo and another pain drug. The study is complete and focused on safety and effectiveness.